Endonovo Therapeutics, Inc. (ENDV) stock
ENDVOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2023, quarter ended Sep 30, 2023Last filing: 10-Q/A on Dec 29, 2023
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $135.08KP/E –Yield –
Endonovo Therapeutics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Endonovo Therapeutics's revenue for the twelve months ending Sep 30, 2023 was $255.72K, up 1699.9% year over year. For fiscal 2022 it was $135.36K, up 85.2% from the year before. Over ten years it grew 10.2% a year on average. The highest annual figure on record is $310.16K in fiscal 2019.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $135.36K | +85.2% |
| FY2021 | Dec 31, 2021 | $73.11K | -55.9% |
| FY2020 | Dec 31, 2020 | $165.80K | -46.5% |
| FY2019 | Dec 31, 2019 | $310.16K | +272.5% |
| FY2018 | Dec 31, 2018 | $83.26K | +1852.2% |
| FY2015 | Dec 31, 2015 | $4.27K | -82.4% |
| FY2014 | Dec 31, 2014 | $24.19K | +5.7% |
| FY2013 | Dec 31, 2013 | $22.90K | -25.1% |
| FY2012 | Dec 31, 2012 | $30.58K | -32.9% |
| FY2011 | Dec 31, 2011 | $45.54K | -11.0% |
| FY2010 | Dec 31, 2010 | $51.20K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2023 | Sep 30, 2023 | $1.52K | -86.1% |
| Q2 FY2023 | Jun 30, 2023 | $45.20K | +6853.8% |
| Q1 FY2023 | Mar 31, 2023 | $87.54K | +3736.1% |
| Q4 FY2022 | Dec 31, 2022 | $121.46K | +38337.7% |
| Q3 FY2022 | Sep 30, 2022 | $10.96K | +40.7% |
| Q2 FY2022 | Jun 30, 2022 | $650 | -97.9% |
| Q1 FY2022 | Mar 31, 2022 | $2.28K | -93.4% |
| Q4 FY2021 | Dec 31, 2021 | $316 | -97.3% |
| Q3 FY2021 | Sep 30, 2021 | $7.79K | -80.5% |
| Q2 FY2021 | Jun 30, 2021 | $30.28K | -32.1% |
| Q1 FY2021 | Mar 31, 2021 | $34.72K | -50.2% |
| Q4 FY2020 | Dec 31, 2020 | $11.50K | -92.3% |
| Q3 FY2020 | Sep 30, 2020 | $39.98K | -26.0% |
| Q2 FY2020 | Jun 30, 2020 | $44.63K | -28.9% |
| Q1 FY2020 | Mar 31, 2020 | $69.69K | +55.0% |
| Q4 FY2019 | Dec 31, 2019 | $148.44K | +252.3% |
| Q3 FY2019 | Sep 30, 2019 | $54.04K | +153.6% |
| Q2 FY2019 | Jun 30, 2019 | $62.73K | +388.0% |
| Q1 FY2019 | Mar 31, 2019 | $44.95K | +544.8% |
| Q4 FY2018 | Dec 31, 2018 | $42.13K | +1434.8% |
| Q3 FY2018 | Sep 30, 2018 | $21.31K | +3.2% |
| Q2 FY2018 | Jun 30, 2018 | $12.85K | -21.7% |
| Q1 FY2018 | Mar 31, 2018 | $6.97K | -60.7% |
| Q1 FY2015 | Mar 31, 2015 | $2.75K | -88.0% |
| Q3 FY2014 | Sep 30, 2014 | $20.64K | – |
| Q2 FY2014 | Jun 30, 2014 | $16.42K | – |
| Q1 FY2014 | Mar 31, 2014 | $17.76K | – |
| Q4 FY2013 | Dec 31, 2013 | $22.90K | – |
| Q3 FY2013 | Sep 30, 2013 | $0 | – |
| Q2 FY2013 | Jun 30, 2013 | $0 | – |
| Q1 FY2013 | Mar 31, 2013 | $0 | – |
See a number that looks wrong?